The latest closing stock price for MaxCyte as of September 19, 2024 is 4.35.
An investor who bought $1,000 worth of MaxCyte stock at the IPO in 2021 would have $-744 today, roughly -1 times their original investment - a -36.51% compound annual growth rate over 3 years.
The all-time high MaxCyte stock closing price was 17.20 on September 03, 2021.
The MaxCyte 52-week high stock price is 5.54, which is 27.4% above the current share price.
The MaxCyte 52-week low stock price is 2.45, which is 43.7% below the current share price.
The average MaxCyte stock price for the last 52 weeks is 4.26.
An investor who bought $1,000 worth of MaxCyte stock at the IPO in 2021 would have $-744 today, roughly -1 times their original investment - a -36.51% compound annual growth rate over 3 years.
The all-time high MaxCyte stock closing price was 17.20 on September 03, 2021.
The MaxCyte 52-week high stock price is 5.54, which is 27.4% above the current share price.
The MaxCyte 52-week low stock price is 2.45, which is 43.7% below the current share price.
The average MaxCyte stock price for the last 52 weeks is 4.26.